Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) targeting inflammatory diseases and oncology due to its ability to modulate biological pathways involving protein kinases. Its structure allows for selective binding and improved metabolic stability in drug candidates. Commonly employed in research and development for novel therapeutic agents in medicinal chemistry.